Skip to content
ExpreS2ion Biotechnologies

ExpreS2ion Biotechnologies

Innovative vaccines for a healthier world

  • Company
    • About us
    • Disease focus
    • AdaptVac
    • Investors & Partners
  • Platform
  • Pipeline
    • Overview
    • ES2B-C001
  • CRO
  • Media
    • Press releases
    • Events
    • Multimedia
    • Publications
  • Investors
  • Careers

Swiss Nordic Bio 2024

  • Home
  • Events
  • Swiss Nordic Bio 2024
Swiss Nordic Bio 2024
Swiss Nordic Bio 2024
favorite_border
  • iCal Export
  • Google Calendar
  • Outlook 365
  • Outlook Live
07 Mar 12:00 AM

Swiss Nordic Bio 2024

Zurich, Switzerland
  • Details
  • Weather
  • Other Events
Swiss Nordic Bio 2024
Zurich, Switzerland

No data found.

ExpreS2ion CFO Keith Alexander will present ExpreS2ion to investors and potential investors. Registration is possible via the Swiss Nordic Bio website

Post navigation

BIO-EUROPE Spring
Aktiespararna Stora Aktiedagarna

Copyright 2010 - All Rights Reserved

R&D
ExpreS2ion Biotechnologies ApS:
CVR/VAT: DK32770487
Agern Allé 1
DK-2970 Hørsholm, Denmark
Contact:
info@expres2ionbio.com
+45 22 22 10 19

Holding Company
ExpreS2ion Biotech Holding AB:
Registration number: 559033-3729
c/o Mindpark
Rönnowsgatan 8C
SE-252 25 Helsingborg, Sweden

Investor relations:
investor@expres2ionbio.com
Partnering:
partnering@expres2ionbio.com
Reagents and kits:
sales@expres2ionbio.com

More info:
Privacy Policy
Terms & General Conditions
Legal Notice & Disclaimer

Copyright © 2026 ExpreS2ion Biotechnologies All rights reserved. Theme: Flash by ThemeGrill. Powered by WordPress
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.